MYX 0.22% $4.52 mayne pharma group limited

Quantifying downside risks, page-154

  1. 318 Posts.
    lightbulb Created with Sketch. 18
    Results cant be under guidance else there would have been a profit downgrade announcement correct? So what has changed apart from DOJ ? Reduced earnings in generics obviously hasn't hurt there revenue(No profit downgrade announcement). Is this purely holders selling due to fear? As shorting has decreased a little >1%
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.